Keep Away Ovarian Cancer Video

In this health video learn how while most of the 22,000 women who are diagnosed with ovarian cancer each year respond to treatment, many of their cancers will return. A new therapy is helping keep that cancer away for good.
Read the full transcript »

Jennifer Matthews: Julie Lee's three new puppies are sure to bring a smile to her face. Julie Lee: They're such a joy. They're so fun!. Jennifer Matthews: She's needed the good times after being diagnosed with stage four ovarian cancer. Julie Lee: My first thought was, Oh my God, I have ovarian cancer. That's like one of the worst cancers you can possibly have. Jennifer Matthews: After chemotherapy and radiation, Julie went into remission. Good news, but Dr. Robert Holloway says 75% of patients in remission have their cancer return. Robert Holloway: Some of the most intense areas of research right now are to try and figure out how to take women who are in remission and keep them there. Jennifer Matthews: Now, researchers are studying a new therapy that may do just that. Catumaxomab or CAT for short is infused right into the abdomen through a port. It links immune cells to cancer cells. The body then creates an immune response to seek out and destroy the cancer cells. Robert Holloway: I can say in the patients that I treated, we have seen the immune response. Jennifer Matthews: Patients are given four injections over a month. Doctors have treated about 36 patients in a clinical trial. It's still early, but so far, all the women have remained in remission. Julie has the injections and has been in remission for nine months. Julie Lee: I hope that this clinical trial prevents me from ever having a relapse again, and I'll stay in remission forever. Jennifer Matthews: She says she wants to enjoy each and every moment with her little pups. This is Jennifer Matthews reporting.

Advertisement
Advertisement
Advertisement